Patent US4965204A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4965204A Expired / Lapsed US ⏱️ 0.0 years remaining

Human stem cells and monoclonal antibodies

Assignee: Johns Hopkins University
•
Filing: 1987-06-01
•
Granted: 1990-10-23
•
Expires: 2007-06-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Monoclonal antibodies that recognize a stage-specific antigen on immature human marrow cells are provided. These antibodies are useful in methods of isolating cell suspensions from human blood and marrow that can be employed in bone marrow transplantation. Cell suspensions containing human pluripotent lympho-hematopoietic stem cells are also provided, as well as therapeutic methods employing the cell suspensions.

Inventors

  • 👤 Curt I. Civin

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 12:44
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; Y; Y10; Y10S; Y10S530/00; Y10S530/808; Y10S530/809

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 129 words
A monoclonal antibody which specifically binds to an antigen on non-malignant, immature human marrow cells, wherein said antigen is stage specific and not lineage dependent, and said antigen is also specifically bound by the antibody produced by the hybridoma deposited under ATCC Accession No. HB-8483; (a) which antigen is present on non-malignant, human blood or bone marrow: (i) colony-forming cells for granulocytes and monocytes (CFC-GM), (ii) colony-forming cells for erythrocytes (BFU-E), (iii) colony-forming cells for eosinophils (CFC-Eo), (iv) multipotent colony-forming cells (CFC-GEMM), and (v) immature lymphoid precursor cells; (b) which antigen is present on a maximum of about 5% non-malignant, human marrow cells and a maximum of about 1% non-malignant, human peripheral blood cells; and (c) which antigen is not present on non-malignant, mature human myeloid and lymphoid cells.
Claim 2
Dependent Claim 129 words
A monoclonal antibody which specifically binds to an antigen on non-malignant, immature human marrow cells, wherein said antigen is stage specific and not lineage dependent, and said antigen is also specifically bound by the antibody produced by the hybridoma deposited under ATCC Accession No. HB-8483; (a) which antigen is present on non-malignant, human blood or bone marrow: (i) colony-forming cells for granulocytes and monocytes (CFC-GM), (ii) colony-forming cells for erythrocytes (BFU-E), (iii) colony-forming cells for eosinophils (CFC-Eo), (iv) multipotent colony-forming cells (CFC-GEMM), and (v) immature lymphoid precursor cells; (b) which antigen is present on a maximum of about 5% non-malignant, human marrow cells and a maximum of about 1% non-malignant, human peripheral blood cells; and (c) which antigen is not present on non-malignant, mature human myeloid and lymphoid cells.
Claim 3
Dependent Claim 22 words
The monoclonal antibody of claim 1 that corresponds to the monoclonal antibody produced by the hybridoma deposited under ATCC Accession No. HB-8483.
Claim 4
Dependent Claim 20 words
The monoclonal antibody of claim 1 that is the antibody produced by the hybridoma deposited under ATCC Accession No. HB-8483.
Claim 5
Dependent Claim 10 words
A hydbridoma which produces a monoclonal antibody of claim 1.
Claim 6
Dependent Claim 10 words
A hybridoma which produces a monoclonal antibody of claim 2.
Claim 7
Dependent Claim 8 words
The hybridoma deposited under ATCC Accession No. HB-8483.
Claim 8
Dependent Claim 8 words
The hybridoma deposited under ATCC Accession No. HB-8483.

References Cited (Backward Citations)

US4381295A Cited
US4364932A Cited
US4624925A Cited
US4364937A Cited
US4582797A Cited
US4381292A Cited
US4443427A Cited
US4710457A Cited
US4714680A Cited
US4714680B1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-10-22 1994-04-23 1994-10-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-10-22 1998-04-23 1998-10-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-10-22 2002-04-23 2002-10-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag